156 related articles for article (PubMed ID: 3585318)
1. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.
Nordberg A; Nyberg P; Adolfsson R; Winblad B
J Neural Transm; 1987; 69(1-2):19-32. PubMed ID: 3585318
[TBL] [Abstract][Full Text] [Related]
2. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor compensation in hippocampus of Alzheimer patients.
Nordberg A; Larsson C; Adolfsson R; Alafuzoff I; Winblad B
J Neural Transm; 1983; 56(1):13-9. PubMed ID: 6133910
[TBL] [Abstract][Full Text] [Related]
4. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
Sakurada T; Alufuzoff I; Winblad B; Nordberg A
Brain Res; 1990 Jun; 521(1-2):329-32. PubMed ID: 1698512
[TBL] [Abstract][Full Text] [Related]
5. Brain muscarinic receptors in senile dementia.
Rinne JO; Laakso K; Lönnberg P; Mölsä P; Paljärvi L; Rinne JK; Säkö E; Rinne UK
Brain Res; 1985 Jun; 336(1):19-25. PubMed ID: 4005573
[TBL] [Abstract][Full Text] [Related]
6. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
[TBL] [Abstract][Full Text] [Related]
7. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
[TBL] [Abstract][Full Text] [Related]
8. Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease.
Ikeda M; Mackay KB; Dewar D; McCulloch J
Brain Res; 1993 Jul; 616(1-2):211-7. PubMed ID: 8395303
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
Henke H; Lang W
Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677
[TBL] [Abstract][Full Text] [Related]
10. VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.
Danielsson E; Eckernäs SA; Westlind-Danielsson A; Nordström O; Bartfai T; Gottfries CG; Wallin A
Neurobiol Aging; 1988; 9(2):153-62. PubMed ID: 2897639
[TBL] [Abstract][Full Text] [Related]
11. Neurotransmitter receptor alterations in Parkinson's disease.
Reisine TD; Fields JZ; Yamamura HI
Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
[No Abstract] [Full Text] [Related]
12. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.
Nordberg A; Nyberg P; Windblad B
Neurochem Pathol; 1985; 3(4):223-36. PubMed ID: 3831845
[TBL] [Abstract][Full Text] [Related]
13. Three-Dimensional Spatial Analyses of Cholinergic Neuronal Distributions Across The Mouse Septum, Nucleus Basalis, Globus Pallidus, Nucleus Accumbens, and Caudate-Putamen.
Carrasco A; Oorschot DE; Barzaghi P; Wickens JR
Neuroinformatics; 2022 Oct; 20(4):1121-1136. PubMed ID: 35792992
[TBL] [Abstract][Full Text] [Related]
14. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
Quirion R; Martel JC; Robitaille Y; Etienne P; Wood P; Nair NP; Gauthier S
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):503-10. PubMed ID: 2878714
[TBL] [Abstract][Full Text] [Related]
16. Age-related differences in brain choline acetyltransferase, cholinesterases and muscarinic receptor sites in two strains of rats.
Michalek H; Fortuna S; Pintor A
Neurobiol Aging; 1989; 10(2):143-8. PubMed ID: 2725809
[TBL] [Abstract][Full Text] [Related]
17. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
Neurosci Lett; 1980 Dec; 20(3):373-7. PubMed ID: 6108540
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
Ruberg M; Ploska A; Javoy-Agid F; Agid Y
Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
[TBL] [Abstract][Full Text] [Related]
19. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
[TBL] [Abstract][Full Text] [Related]
20. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
